AIM•benzinga•
AIM ImmunoTech Form 4 Filing Shows CEO Thomas K Equels Bought 50,000 Shares At An Average Price Of $0.13/Share
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 6, 2025 by benzinga